台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.8
  • 漲跌
    ▼0.2
  • 漲幅
    -0.33%
  • 成交量
    26
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-康和-嘉義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

康和-嘉義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/2000.00165.3064.40-191-1.10%
2024/11/1900.000.469.5069.30-0.488-0.45%
2024/11/15169.80171.5072.6001010.00%
2024/11/14875.05872.0169.7001020.00%
2024/11/1200.000.386.0086.00-0.390-0.33%
2024/10/0900.00197.4097.40-1138-0.72%
2024/09/2000.00296.3096.30-2139-1.43%
2024/09/18196.6000.0096.2011390.72%
2024/08/221102.5000.00102.0011360.73%
2024/08/191107.0000.00106.0011300.77%
2024/07/0400.001101.50102.50-1128-0.78%
2024/06/2100.000101.00100.500140-0.03%
2024/06/2000.000.3101.00101.00-0.3142-0.21%
2024/06/0700.001102.50102.50-1155-0.64%
2024/04/121117.0000.00118.0011040.96%
2024/03/271122.0000.00122.001661.51%
2023/10/2400.001116.50116.00-122-4.49%
2023/10/2300.001116.00117.00-122-4.42%
2023/10/202117.0000.00117.002238.60%
2023/03/3000.001117.50118.00-135-2.82%
2023/03/231116.0000.00115.001293.34%
2022/09/0500.001109.50108.00-117-5.67%
2022/09/021108.5000.00109.501175.61%
2022/05/1300.007101.79102.50-740-17.49%
2022/05/1200.000.9109.00109.00-0.933-2.68%
2022/04/272120.0000.00121.502257.70%
2022/04/152125.0000.00124.502257.76%
2022/03/290.1132.0000.00133.500.1200.49%
2022/03/231130.0000.00130.501195.17%
2022/02/072125.0000.00125.002219.24%
2021/10/130.2126.1500.00125.000.2400.46%
2021/10/120.2133.7500.00132.500.2370.54%
2021/09/060.1148.0000.00147.000.1330.30%
2021/09/030.1147.5000.00147.000.1330.30%
2021/09/010.1148.0000.00147.000.1350.28%
2021/08/101150.5000.00152.501352.82%
2021/08/020.1155.0000.00155.000.1340.29%
2021/07/280.2151.0000.00150.000.2320.61%
2021/07/210.1151.5000.00151.000.1320.31%
2021/07/150.1151.0000.00151.000.1320.31%
2021/07/140.2151.2500.00150.500.2320.61%
2021/07/120.1151.5000.00150.500.1330.30%
2021/07/050.1152.0000.00153.500.1390.25%
2021/07/020.1151.5000.00152.000.1390.25%
2021/06/300.1151.5000.00152.000.1400.25%
2020/07/1500.000.1106.00107.00-0.163-0.21%
2020/06/2400.001115.50116.00-159-1.67%
2020/06/051113.5000.00113.001551.79%
2020/05/2000.001109.00109.00-152-1.92%
2020/05/191107.0000.00107.001511.95%
2020/05/1400.001108.50108.50-149-2.00%
2020/05/121107.0000.00108.001472.11%
2019/08/1200.005.5101.09101.50-5.542-12.84%
2019/06/2100.001111.00109.50-140-2.45%
2019/06/0300.001110.00110.00-142-2.36%
2019/04/1600.000.1109.50109.50-0.137-0.15%
2019/03/270.6109.5000.00109.500.6311.96%
2019/03/260.1110.0000.00111.000.1300.26%
2018/09/2000.001105.50105.00-150-1.97%
2018/09/1000.001105.00104.50-153-1.88%
2018/05/111125.0000.00124.5011300.77%
2018/05/0400.000.2128.50128.50-0.2117-0.17%
2018/03/2200.001129.00125.50-1170-0.59%
2018/03/210.1128.500.1128.50128.5001830.00%
2018/03/191128.0000.00127.5011760.57%
2018/02/121114.0000.00113.5011670.60%
2018/02/0600.001116.00112.00-1165-0.61%
2018/01/3100.001120.00120.00-1163-0.61%
2018/01/251125.0000.00123.5011610.62%
2018/01/191127.001129.50124.0001480.00%
2018/01/180.1121.0000.00121.500.11340.07%
2018/01/155113.0000.00118.0051144.35%
2018/01/111109.0000.00110.0011040.96%
2018/01/0300.001108.50109.50-196-1.03%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音